Search

everythinglearnresearchcommunity

for

Search:↓

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

A patient with complete hair loss regrew all her hair using tofacitinib.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

Tofacitinib may help regrow hair in alopecia areata patients.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Imatinib can cause hair loss due to lichen planopilaris.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

The combination therapy was effective and well-tolerated, especially in young patients.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Erlotinib can cause unexpected side effects like eyelash growth and scarring.

Cetuximab can cause unusual hair growth and hair loss.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.